Related Experiment Video
Updated: Jun 5, 2026

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
Published on: May 5, 2021
[The effects of glycemic control on ophthalmic refraction in diabetic patients]
Hai-yan Li1, Guo-chun Luo, Jiang Guo
1Department of Endocrinology, the Second People's Hospital of Shenzhen, Shenzhen, China.
Objective:
To evaluate effects of glycemic control on refraction in diabetic patients.
Methods:
Twenty newly diagnosed diabetic patients were included in this study. The random blood glucose, glycosylated hemoglobin A1c (HbA1c) levels, fasting C-peptide and postprandial 2 h C-peptide levels were measured before treatment. The patients with random blood glucose ≥ 12.0 mmol/L and HbA1c ≥ 10.0% were selected. Refraction, intraocular pressure, radius of the anterior corneal curvature, depth of the anterior chamber, lens thickness, vitreous length, and axial length were measured on admission and at the end of week 1, 2, 3 and 4 during glycaemic control.
Results:
A transient hyperopic change occurred in all the patients receiving glycemic control with a mean maximum hyperopic changes of 1.6 D (0.50 D ∼ 3.20 D). There was a positive correlation between the magnitude of the maximum hyperopic changes and the HbA1c levels on admission (r = 0.84, P < 0.05). There was a positive correlation between the magnitude of the maximum hyperopic changes and the daily rate of blood glucose reduction over the first 7 days of the treatment (r = 0.53, P < 0.05). There was no significant correlation between the magnitude of the maximum hyperopic changes and the levels of random blood glucose on admission. No significant correlation was observed between the maximum hyperopic changes and fasting C-peptide or postprandial 2 h C-peptide. There were no significant correlations between the magnitude of the maximum hyperopic changes and age, blood press, body mass index, triglyceride, total cholesterol, low-density lipoprotein or high-density lipoprotein. No significant changes were observed in the intraocular pressure, radius of the anterior corneal curvature, depth of the anterior chamber, lens thickness, vitreous length and axial length during glycemic control.
Conclusions:
Transient hyperopic changes occur after glycemic control in diabetic patients with severe hyperglycaemia. The degrees of transient hyperopia are highly dependent on HbA1c levels before treatment and the rate of reduction of glucose level over the first 7 days of treatment. This is probably due to the decrease of refractive power by lens hydration, not morphological change of lens.
Insights
Glycemic control in diabetic patients with severe hyperglycemia can cause temporary hyperopic shifts. These refractive changes depend on initial HbA1c levels and the speed of glucose reduction.
Area of Science:
- Ophthalmology
- Endocrinology
- Metabolic Disorders
Context:
- Diabetic patients with severe hyperglycemia often experience fluctuating vision.
- Glycemic control is crucial for managing diabetic complications.
- Understanding refractive changes is important for patient eye care.
Purpose:
- To investigate the impact of glycemic control on refractive error in diabetic patients.
- To correlate refractive changes with glycemic control parameters.
- To identify factors influencing transient hyperopia in diabetes.
Summary:
- Twenty newly diagnosed diabetic patients with high blood glucose and HbA1c levels were studied.
- A transient hyperopic shift was observed in all patients undergoing glycemic control.
- Hyperopic changes correlated positively with admission HbA1c and the rate of glucose reduction.
Impact:
- This study highlights transient hyperopia as a potential consequence of aggressive glycemic control in diabetes.
- Findings suggest lens hydration, not morphological changes, causes these refractive shifts.
- Ophthalmologists and endocrinologists should be aware of these visual disturbances.
Related Concept Videos
Diabetic Retinopathy
Hyperglycemia
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Nephropathy
Diabetes Mellitus: Type 2 and Gestational
Angle Closure Glaucoma: Treatment

